What Caused the Collapse of Silicon Valley Bank?

"Worst-Case Scenario": Novo Nordisk Plunges After Next-Gen Obesity Drug Falls Short Of Lilly Rival Shares of Novo Nordisk A/S plummeted again on Monday after the company reported trial results showing its next-generation obesity shot, CagriSema, delivered 20.2% weight loss at 84 weeks, compared to 23.6% for Eli Lilly & Co.’s tirzepatide (Zepbound). Bloomberg Intelligence analyst Michael Shah explained, "This outcome is the worst-case scenario for Novo and heightens the need for M&A with Novo’s other GLP-1/Amylin drug." Shares of Novo in Copenhagen plunged as much as 16.5%, breaking below a support level...

This event shows how entrepreneurs are advancing free-market solutions beyond our broken political system, with speakers highlighting real-world alternatives in health care, entrepreneurship, and economic policy.

When it comes to foreign policy, what matters are powerful interest groups. The ordinary voters who pay all the bills don't matter. The interest groups pushing for pro-Israel wars in the Middle East are especially powerful.